Pazopanib improves progression free survival in adults with certain soft tissue sarcomas
Results of the EORTC 62072 PALETTE (PAzopanib ExpLorEd in SofT-Tissue [...]
International Rare Cancer Initiative EORTC – UK – US Global Collaboration
Posted on 23 November 2011
The EORTC has joined forces with Cancer Research UK, the National Institute for Health Research Cancer Research Network (NCRN), and the United States National Cancer Institute (NCI) to launch an initiative to boost the development of new treatments for patients with rare cancers.
International Rare Cancer Initiative EORTC – UK – US Global Collaboration
The EORTC has joined forces with Cancer Research UK, the National Institute for Health Research Cancer Research Network (NCRN), and the United States National Cancer Institute (NCI) to launch an initiative to boost the development of new treatments for patients with rare cancers.
EORTC, BIG, and Agendia Announce: Completion of Patient Recruitment for International MINDACT Study
Brussels, Belgium, IRVINE, CA, and AMSTERDAM, THE NETHERLANDS, 18 October 2011 – The EORTC, BIG, and Agendia, a commercial-stage molecular cancer diagnostics company, today announced the completion of patient registration for the EORTC 10041/BIG3-04 MINDACT (Microarray In Node negative and 1-3 positive lymph node Disease may Avoid Chemotherapy Trial) study.
Choice of antiepileptic drug for brain tumor patients may affect survival
Posted on 12 October 2011
New research suggests brain tumor patients who take the antiepileptic drug valproic acid on top of standard treatment may live a few months longer than people who take other kinds of epilepsy medications to control seizures. The research is published in the 31 August 2011 online issue of Neurology®, the medical journal of the American Academy of Neurology.
EORTC staff participate in Relay for Life in Brussels
Led by Edwin Nys, Data Manager at EORTC Headquarters, a team of 30 EORTC staff members took turns running or walking around the track for the benefit of cancer patients. Edwin, emblematic of the dedication of all EORTC Headquarters staff, resolutely participated for the entire 24 hours of the relay. In all, eighteen teams participated in this year’s Relay For Life event held at Tour & Taxis in Brussels on 27/28 August 2011, and the participating teams collected over €25000 for the fight against cancer.
Recruitment in Brain Tumor Group trial benefits from intergroup collaboration
The EORTC 26081-22086 Codel trial was activated by the EORTC on 22 December 2010, the first patient was enrolled on 25 February 2011, and eleven patients have already been enrolled by EORTC institutions (one patient each in Austria and France, two in B
1st St.Gallen EORTC Gastrointestinal Cancer Conference will be held 22-24 March 2012 in St. Gallen, Switzerland
St.Gallen EORTC Gastrointestinal Cancer Conference (SG-GICC 2012) will be held 22-24 March 2012 in St. Gallen, Switzerland. This new bi-annual conference will focus on primary therapy of early, potentially cureable cancers of the gastrointestinal tract. This conference alternates with the St.
New EORTC studies opened in 2011
Studies that were open since the beginning of this year, and the ones that will soon be opening.
